{"name":"Trevi Therapeutics","slug":"trevi-therapeutics","ticker":"","exchange":"","domain":"trevi.com","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"Pharma / Biotech","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"Nalbuphine ER","genericName":"Nalbuphine ER","slug":"nalbuphine-er","indication":"Other","status":"marketed"}]}],"pipeline":[{"name":"Nalbuphine ER","genericName":"Nalbuphine ER","slug":"nalbuphine-er","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMi1wFBVV95cUxPTmlTS0Z5M1U3Uk5EVGRsQi0yTWNVQjFNOFFla2RQOFI1RzJZaUZaRWxTck5UZy00WXp0NmQ1UGJuU2Y2R0ptcXlCaUpfWmtRTl95dXd4M2haMG5aX0lpWjFGSXduUGstblpISkp0WWZpSTFjMmFDcm5maktzd1NGbTFwTndGWDhFQ2d0RDk1OElNMnVfWVdILWxDNzkwWUV0dTBWQjhVaUtLOWVIUTd1VjRzNm1ZYlBucUY0UEk1QmhLekFkNW9fdDhWMGxsUTk5T2tFaVdMMA?oc=5","date":"2026-02-10","type":"pipeline","source":"hartfordbusiness.com","summary":"New Haven biotech Trevi Therapeutics builds billion-dollar valuation around lone late-stage cough drug - hartfordbusiness.com","headline":"New Haven biotech Trevi Therapeutics builds billion-dollar valuation around lone late-stage cough drug","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMickFVX3lxTE5qNTMwWUZZb3NxMERUREE5T2Z2Vk5Jd2dXNTBQRjNidVBjYVI2RlZGQ3A4UjhmM2Qya1hIbDNFUGp1UV95SU9uVXowbXdZRjNrSjdmVEZHRUlkN2RxQ2ZfbUJmY2lTdkhZQXdpbk9UMXJRdw?oc=5","date":"2026-01-23","type":"pipeline","source":"MedPage Today","summary":"Novel Opioid Receptor Drug Cuts IPF Cough - MedPage Today","headline":"Novel Opioid Receptor Drug Cuts IPF Cough","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiiAJBVV95cUxQMDNrWVJ2cFVEVjhLbzd2cE11bmJseTVkSTY5TXUxMFVoT2RtemxnMVZhWkRuWWVQSkkzOV9GdDNubnEyVjY3VGNVaHd6NHR3WTRmRXJJZGN3Vk93ZHhuQkNaMV9xd01Dd2c5aDRiXzd6Xzl0T1hjbXNQdzlDQThwa1psc2RWN0EyNnM2T3V1VHRPRzVmUXBzb2FhUGdGM2hqZXBZek5nQTdEdFN1Q2R1SXVxeGNkc1pKVFgySUlMWHYydjJ4bHZWamJKX1RreFA2NTlma2ZLTklwWjdtSmNRdEgyTzZ6LWozTTFJN1VYQTR0eDlGQzdnd21zY0ZWdmZTVy1xMjctc2U?oc=5","date":"2026-01-08","type":"pipeline","source":"Benzinga","summary":"Immuneering, Phathom Pharmaceuticals, Canadian Solar And Other Big Stocks Moving Lower In Thursday's Pre - Benzinga","headline":"Immuneering, Phathom Pharmaceuticals, Canadian Solar And Other Big Stocks Moving Lower In Thursday's Pre","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilgFBVV95cUxNQ2FGQ1lsdmVXZGhHcTM1dnZPN0s1WnBTem5fVjJuMWdxRlhtMi1kdW1UN3RCaEhIQTYxMTZ0Wkk0QXhpX1Atd2hickRfbUpFME94S2duaGVXNTMwUTFhNFp6QjNzLXJmdS1iRkxLTGpsVmJpOUVtRWstem55ODk2Sk9mS3VoekpjaXhkSlJPMEdwXzU2WGc?oc=5","date":"2025-12-04","type":"pipeline","source":"Contract Pharma","summary":"Trevi Therapeutics Taps David Hastings as CFO - Contract Pharma","headline":"Trevi Therapeutics Taps David Hastings as CFO","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMingFBVV95cUxOWTR2M3JlU2M5bzJiY00tNFNmSTRVNUxzbXF1d0JRbVMxV2doRm9pUENPakN0amw3VHJEUldXY1dnYWlhVld4RW9DY2VsMmdjaVBEaVI2WnNnSXBDTHp0ZlktVnlmSERvY3poTndNdllicm5hMFhuZkVyOWJvWFNUdEFQeVBSeEN2cGhfT1YwUUxOdEVJY1IyZ0ZMSXF5QQ?oc=5","date":"2025-11-27","type":"trial","source":"Mugglehead Magazine","summary":"Trevi Therapeutics jumps 20% on study linking GLP-1 drugs to Chronic Cough - Mugglehead Magazine","headline":"Trevi Therapeutics jumps 20% on study linking GLP-1 drugs to Chronic Cough","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilwJBVV95cUxPaXRELXRlVG9TNUMwN1ZMX3NsM2dzaGp1b0I5ZmtUaF9oWUQxWkZGMGN0cm1ZZ1AtR2U0LVNlOVB0X2xHTE9Ub29yWXU4Vm9TTmtLTHNocXpJOFk3QnJQRDNrcmxGcE11TURRZE54RS02RjZRX3FNOXA3cDVHWjBDY09GdHhJMzh2MEtVMTdzSlZQQWZfUDhSUS14UHZZTWZWRHVvRHdMa2tsc1J0S1E5QTJTQ01IT0VwYTFjalVVcVAtaVVrVFZYVklSVVVucFVIU3BieGw5ajZ3WTFPekNoemlqVFdlUE9LcE1Pa0R4b0tYdzFvMzhmZWF2LVVPYmRvbWJLd3RQM1BHblZjYkRRRG8zMHJvZms?oc=5","date":"2025-11-24","type":"pipeline","source":"globenewswire.com","summary":"Chronic Refractory Cough Market is Expected to Boom by 2034 - globenewswire.com","headline":"Chronic Refractory Cough Market is Expected to Boom by 2034","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMinAFBVV95cUxQVG9VdjJMMnJWVldwRVZReXBfVzF3dy1RczNLNFdQVm5hRDlyNWllNGhsWFlSSTN5cUZOX0NoT0V2NkNwX2ZMd0RKUWNFREQ1Yl80eFl4MGNRQU4zNm4wREM5TlM5UUJmQS14bXVuckRKV3ZSVS1HWGpZeUs3cDBOT0VweUVjUXoyZi03R2wySHlYME51akpMRGVXMjg?oc=5","date":"2025-11-17","type":"trial","source":"seekingalpha.com","summary":"Trevi Therapeutics: Big Cough Data, Bigger Execution Risk (NASDAQ:TRVI) - seekingalpha.com","headline":"Trevi Therapeutics: Big Cough Data, Bigger Execution Risk (NASDAQ:TRVI)","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi3gFBVV95cUxQTDRoMU9iek1kU29pMXZjQ3phVFZHaHNVdUVNRTRtamowVzVONE1lRzFJWVZOUUlNRG51TnMxOV94ZnJnNkhKN244VDZJWXhrSE1jTkE5Zjc5S3o3aHZIMmg5TEpacnhZOC1vU3pZQjBqWEFTcWcxNjdJUjZQVkV5UUlrcnR2U3RoTndlMEg2ZVdzUjlVQkVqNkMyNDBWMjU4WExlTnUzWDVRdS1XZEJRLVVCNTN0WnNzUXlHYVAtNlpMVGtsc2FDRUxEYTFuNnVRNzJab3VtS3VDYWFfWmc?oc=5","date":"2025-06-03","type":"pipeline","source":"PR Newswire","summary":"Trevi Therapeutics Announces Pricing of $100 Million Underwritten Offering of Common Stock - PR Newswire","headline":"Trevi Therapeutics Announces Pricing of $100 Million Underwritten Offering of Common Stock","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikAJBVV95cUxNUC1NNU9OVnNCUmJweUJjcm5WX19adUh3NG82TGtiMmJEc2Q4Z3VoOEs5TTY4R3lZWVE3RVRyVEthYl9YcExQUzQ1RmdCZkZfRDR0SE82QlQ0Z2hiZUlGZngzRW1oVEVMMEs2OUJqcldqeW5sYUdmaWJlNHIxbHZjQ05wbVNpaWRmbGMza3hPZFhXd3lGZlE2RHR6VHFqUUppNHBlNnZEb2hPLWVwYVNXaGZuZzI5bGFJaEhfQUhIUGkxMTF2bVNWZWVNaWU3VFZDUVFSc3dMc3RrdldHdGZYU0d4bDhtT1BtQmJlZkFBUllxakJtcWZDbng2ZlhQR2FnUFZlNHJRRHBhcXZlZmN4MQ?oc=5","date":"2025-05-20","type":"trial","source":"PR Newswire","summary":"Trevi Therapeutics Announces Additional Analyses from Phase 2a RIVER Trial of Haduvio in Patients with Refractory Chronic Cough - PR Newswire","headline":"Trevi Therapeutics Announces Additional Analyses from Phase 2a RIVER Trial of Haduvio in Patients with Refractory Chroni","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiU0FVX3lxTE5RaTc1anowU0tobFpQZ1hXcXhSaGJzNGFxb3hRcDhVckFMZVlVb0JRaEtlQzZBamdFWlZQUmxBQTFwTG0zRWJqR3RBYTBtVlo5bGxN?oc=5","date":"2025-03-10","type":"pipeline","source":"FirstWord Pharma","summary":"Trevi soars on hopes for refractory chronic cough treatment - FirstWord Pharma","headline":"Trevi soars on hopes for refractory chronic cough treatment","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMif0FVX3lxTE1YXzlUeXlWTVlFNFJjeGQtaG5hSWZYR2llTG53YzJHUDJ2QUo2OUJNeUVwVVR1X3J5Vi15anp5UW5nWUtiVU44V1dqZWhUWFFDQUVOeWZHdnB5VHRCcmlWUXB3N2tnVnRRWTZCdndoa2xabjNIak1PbWlzMmV1Rmc?oc=5","date":"2023-11-03","type":"trial","source":"Clinical Trials Arena","summary":"Trevi Therapeutics begins trial of chronic cough treatment - Clinical Trials Arena","headline":"Trevi Therapeutics begins trial of chronic cough treatment","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMifkFVX3lxTE5oUTJkQi1YUTZhdEtnckJDaGVQTDhLa0NtNDFrWlA4X3U2dGQ2cFJBMXFBajVfdEFhMl9CLUtaRGFjaUZPUjRtWlVJNktFU1JvSEtBeUJHQUFFdlZoVDJwZFpWZ3pteGwzWjhrZDdrTlFVeXVaZmxYd3E1TVlCdw?oc=5","date":"2023-04-26","type":"pipeline","source":"Pharma Voice","summary":"Woman of the Week: Trevi Therapeutics’ Jennifer Good - Pharma Voice","headline":"Woman of the Week: Trevi Therapeutics’ Jennifer Good","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"marketed":1},"enrichmentLevel":0,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}